A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 17, 2025

Study Completion Date

August 17, 2025

Conditions
Resistant Hypertension
Interventions
DRUG

Baxdrostat

"Baxdrostat tablet administered orally, once daily (QD). Unit dose strength:~• 2 mg per tablet."

DRUG

Placebo

Placebo tablet matching baxdrostat, administered orally, once daily (QD).

Trial Locations (102)

220

Research Site, New Taipei City

333

Research Site, Taoyuan District

1115

Research Site, Budapest

1148

Research Site, Budapest

1527

Research Site, Sofia

1618

Research Site, Sofia

1680

Research Site, Sofia

2009

Research Site, Angeles City

3168

Research Site, Clayton

4000

Research Site, San Miguel de Tucumán

4001

Research Site, Durban

4400

Research Site, Nyíregyháza

5000

Research Site, Iloilo City

5006

Research Site, San Vicente

6000

Research Site, Perth

6300

Research Site, Kalocsa

7500

Research Site, Cape Town

7635

Research Site, Pécs

9000

Research Site, Ghent

10330

Research Site, Bangkok

10400

Research Site, Bangkok

10455

Research Site, The Bronx

10700

Research Site, Bangkok

11217

Research Site, Taipei

11426

Research Site, Riyadh

11462

Research Site, Riyadh

11527

Research Site, Athens

Research Site, Attica

12203

Research Site, Berlin

15586

Research Site, Kota Bharu

19047

Research Site, Langhorne

26080

Research Site, Odunpazari

27834

Research Site, Greenville

28040

Research Site, Madrid

28041

Research Site, Madrid

28401

Research Site, Wilmington

28504

Research Site, Kinston

28546

Research Site, Jacksonville

28562

Research Site, New Bern

33024

Research Site, Hollywood

33467

Research Site, Lake Worth

33952

Research Site, Port Charlotte

38039

Research Site, Kayseri

40002

Research Site, Muang

40503

Research Site, Lexington

46010

Research Site, Valencia

46100

Research Site, Kahramanmaraş

46804

Research Site, Fort Wayne

50200

Research Site, Chiang Mai

54642

Research Site, Thessaloniki

55001

Research Site, Broumov

60590

Research Site, Frankfurt

61348

Research Site, Bad Homburg

67655

Research Site, Kaiserslautern

76550

Research Site, Lampasas

78404

Research Site, Corpus Christi

78526

Research Site, Brownsville

84000

Research Site, Muar town

85374

Research Site, Surprise

98000

Research Site, Sarawak Miri

100000

Research Site, Hanoi

700000

Research Site, Ho Chi Minh City

Research Site, Hochiminh City

C1119ACN

Research Site, CABA

C1425AGC

Research Site, CABA

C1060ABN

Research Site, Capital Federal

X5003DCP

Research Site, Córdoba

B1824KAJ

Research Site, Lanús Este

S2000PBJ

Research Site, Rosario

T6G 2C8

Research Site, Edmonton

V7M 2H4

Research Site, North Vancouver

N1R 6V6

Research Site, Cambridge

M6G 1M2

Research Site, Toronto

N2T 0C1

Research Site, Waterloo

G7H 7K9

Research Site, Chicoutimi

J6X 4P7

Research Site, Terrebonne

256 01

Research Site, Benešov

250 01

Research Site, Brandýs nad Labem

440 01

Research Site, Louny

15-540

Research Site, Bialystok

80-214

Research Site, Gdansk

30-688

Research Site, Krakow

91-002

Research Site, Lodz

61-848

Research Site, Poznan

04-628

Research Site, Warsaw

977 01

Research Site, Brezno

04022

Research Site, Košice

08901

Research Site, Svidník

08003

Research Site, Barcelona

08036

Research Site, Barcelona

08923

Research Site, Santa Coloma de Gramenet

08221

Research Site, Terrassa (Barcelona)

01060

Research Site, Adana

06230

Research Site, Ankara

NN17 2UR

Research Site, Corby

E1 1BB

Research Site, London

W6 7HY

Research Site, London

L35 5DR

Research Site, Prescot

SN3 6BB

Research Site, Swindon

IP24 1JD

Research Site, Thetford

BS24 7PR

Research Site, Weston-super-Mare

BS37 4AX

Research Site, Yate

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY